Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines

NCT02797028 is registered in ClinicalTrials.gov with Guangzhou General Hospital of Guangzhou Military Command as lead sponsor.

NCT NCT02797028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02797028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by Anthocyanidines
Lead sponsor
Guangzhou General Hospital of Guangzhou Military Command
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2015
Completion date
December 31, 2017
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease